Lineage

May 14, 2020viewing Agreed to Senate Mr. Durbin (for himself, Mr. Schumer, Mrs. Murray, Mr. Leahy, Mr. Menendez, Mr. Murphy, Ms. Duckworth, Mr. Coons, Mr. Udall, Mr. Bennet, Mr. Booker, Mr. Van Hollen, Mr. Blumenthal, Mr. Reed, Mrs. Gillibrand, Mr. Casey, Mr. Brown, Ms. Hassan, Mrs. Feinstein, Ms. Cantwell, Mr. Heinrich, Ms. Warren, Mr. Cardin, Ms. Hirono, Mr. Markey, Ms. Baldwin, Mr. Wyden, Ms. Cortez Masto, Mr. Sanders, Mrs. Shaheen, Mr. Whitehouse, Ms. Rosen, Mr. Kaine, Ms. Smith, Mr. King, Mr. Warner, Mr. Schatz, Ms. Klobuchar, Mr. Merkley, Mr. Carper, and Ms. Harris) submitted the following resolution; which was referred to the Committee on Foreign Relations See what changed
May 14, 2020 Introduced in Senate Mr. Durbin (for himself, Mr. Schumer, Mrs. Murray, Mr. Leahy, Mr. Menendez, Mr. Murphy, Ms. Duckworth, Mr. Coons, Mr. Udall, Mr. Bennet, Mr. Booker, Mr. Van Hollen, Mr. Blumenthal, Mr. Reed, Mrs. Gillibrand, Mr. Casey, Mr. Brown, Ms. Hassan, Mrs. Feinstein, Ms. Cantwell, Mr. Heinrich, Ms. Warren, Mr. Cardin, Ms. Hirono, Mr. Markey, Ms. Baldwin, Mr. Wyden, Ms. Cortez Masto, Mr. Sanders, Mrs. Shaheen, Mr. Whitehouse, Ms. Rosen, Mr. Kaine, Ms. Smith, Mr. King, Mr. Warner, Mr. Schatz, Ms. Klobuchar, Mr. Merkley, and Mr. Carper) submitted the following resolution; which was referred to the Committee on Foreign Relations

S. Res. 579 — what changed

Encouraging the international community to remain committed to collaboration and coordination to mitigate and prevent the further spread of COVID–19 and urging renewed United States leadership and participation in global efforts on therapeutics and vaccine development and delivery to address COVID–19 and prevent further deaths, and for other purposes.

From Introduced in Senate to Agreed to Senate. 1 section amended between Introduced in Senate and Agreed to Senate.

That the Senate—

(1)

renumbered was (1) recognizes the historic leadership role of the United States in stemming global health crises in the past;

(2)

added commends the historic achievements of the international community to address global public health threats, such as the eradication of smallpox and dramatic progress in reducing cases of polio;

(2)

removed commends the historic achievements of the international community in addressing global public health crises, such as the eradication of smallpox and dramatic progress in reducing cases of polio and Ebola;

(3)

renumbered was (3) encourages the international community to remain committed to collaboration and coordination to mitigate and prevent the further spread of COVID–19;

(4)

added commends the promising research and development underway to develop COVID–19 diagnostics, therapies, and vaccines within the United States and with support from the Federal government, public-private partnerships, and commercial partners;

(4)

removed ~~commends the promising research underway to develop COVID–19 therapies and a vaccine within the United States and with support from Federal agencies;~~

(5)

renumbered was (5) acknowledges the vast international research enterprise and collaboration underway to study an expansive range of drug and vaccine candidates;

(6)

removed ~~urges renewed United States leadership and participation in any global efforts on therapeutics and vaccine development and delivery to address COVID–19 and prevent further American deaths; and~~

(6)

changed ~~calls on the~~ urges renewed United States ~~Government to boost funding for,~~ leadership and ~~strengthen collaboration with, key multilateral institutions at the forefront of responding~~ participation in global efforts on therapeutics and vaccine development and delivery to address COVID–19 ~~such as the Coalition for Epidemic Preparedness Innovations; GAVI, the Vaccine Alliance;~~ and ~~the Solidarity trial.~~prevent further American deaths; and

(7)

added calls on the United States Government to strengthen collaboration with key partners at the forefront of responding to COVID–19.

S. Res. 579 — what changed

Cite this provision

Incoming references